Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | THRA | P10827 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3179450 | 0.89 | PTGS2 (0.46) | PTGS2CYP3A4GPR84HTTLMNA | |
| SCHEMBL21820388 | 0.83 | MAPT (0.33) | PTGS2MAPTKMT2AMEN1HTT | |
| SCHEMBL11792292 | 0.82 | DRD2 (0.42) | CYP3A4CNR1CNR2NR1H2NR1H3 | |
| SCHEMBL13837705 | 0.80 | LPL (0.44) | CNR1CNR2MAPTKMT2ALMNA | |
| SCHEMBL11070425 | 0.73 | LPL (0.38) | PTGS2CYP3A4GPR84CNR1CNR2 | |
| SCHEMBL7700304 | 0.72 | CNR1 (0.46) | PTGS2CYP3A4GPR84CNR1CNR2 | |
| SCHEMBL14028574 | 0.72 | CRHR1 (0.43) | MAPTKMT2AMEN1HTTLMNA | |
| SCHEMBL9220960 | 0.71 | ACHE (0.43) | PTGS2CYP3A4GPR84CNR1CNR2 | |
| SCHEMBL11792373 | 0.71 | ESR1 (0.55) | PTGS2CYP3A4KMT2AMEN1LMNA | |
| SCHEMBL43166 | 0.70 | MAPT (0.38) | MAPTKMT2AMEN1HTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9511004-B2 | Dental material, dental material composition, dental restorative material, and cured product | MITSUI CHEMICALS, INC. (JP) | 2016-12-06 | — | — | US | disclosed |
| US-9504632-B2 | Compound, composition comprising the compound and cured product | MITSUI CHEMICALS, INC. (JP) | 2016-11-29 | — | — | US | disclosed |
| US-20120296003-A1 | DENTAL MATERIAL, DENTAL MATERIAL COMPOSITION, DENTAL RESTORATIVE MATERIAL, AND CURED PRODUCT | MITSUI CHEMICALS, INC (JP) | 2012-11-22 | — | — | US | disclosed |
| US-20120296005-A1 | MEDICAL RESIN COMPOSITION, MANUFACTURING PROCESS THEREFOR AND MEDICAL KIT | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2012-11-22 | — | — | US | disclosed |
| US-20120296061-A1 | NOVEL COMPOUND, COMPOSITION COMPRISING THE COMPOUND AND CURED PRODUCT | MITSUI CHEMICALS, INC. (JP) | 2012-11-22 | — | — | US | disclosed |
| US-8124669-B2 | Dental composition | KURARAY MEDICAL INC. (JP) | 2012-02-28 | — | — | US | disclosed |
| US-7951851-B2 | Curable composition for dental purposes | KURARAY MEDICAL INC. (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20110003267-A1 | DENTAL COMPOSITION | KURARAY MEDICAL INC. (JP) | 2011-01-06 | — | — | US | disclosed |
| US-20100105802-A1 | CURABLE COMPOSITION FOR DENTAL PURPOSES | KURARAY MEDICAL INC. (JP) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105802-A1 | CURABLE COMPOSITION FOR DENTAL PURPOSES | H1-0, H1-3, H1-2 | PTGS2 869/4885CYP3A4 4212/4885GPR84 3010/4885 |
| US-20110003267-A1 | DENTAL COMPOSITION | NLRP3, TAS2R42, CAD | PTGS2 1972/4885CYP3A4 1281/4885GPR84 545/4885 |
| US-20120296061-A1 | NOVEL COMPOUND, COMPOSITION COMPRISING THE COMPOUND AND CURED PRODUCT | GGPS1, FDFT1, FDPS | PTGS2 280/4885CYP3A4 1312/4885GPR84 3949/4885 |
| US-20120296003-A1 | DENTAL MATERIAL, DENTAL MATERIAL COMPOSITION, DENTAL RESTORATIVE MATERIAL, AND CURED PRODUCT | CAD, SEM1, REV1 | PTGS2 578/4885CYP3A4 4021/4885GPR84 4163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.